Jiangsu Jibeier Pharmaceutical Co Ltd (688566) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Jiangsu Jibeier Pharmaceutical Co Ltd (688566) has a cash flow conversion efficiency ratio of 0.005x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥11.07 Million ≈ $1.62 Million USD) by net assets (CN¥2.37 Billion ≈ $346.78 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 688566 market cap for the company's overall valuation and market capitalisation.
Jiangsu Jibeier Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2016–2025)
This chart illustrates how Jiangsu Jibeier Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Jiangsu Jibeier Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Jiangsu Jibeier Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Explore how high is Jiangsu Jibeier Pharmaceutical Co Ltd's earnings quality to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Kardemir Karabuk Demir Celik Sanayi ve Ticaret AS Class D
IS:KRDMD
|
0.031x |
|
Peapack-Gladstone Financial
NASDAQ:PGC
|
0.072x |
|
Zhejiang Zhaofeng Mechanical and Electronic Co Ltd
SHE:300695
|
0.000x |
|
Kopin Corporation
NASDAQ:KOPN
|
-0.063x |
|
Sichuan Huiyu Pharmaceutical Co Ltd
SHG:688553
|
0.016x |
|
Thungela Resources Limited
JSE:TGA
|
0.156x |
|
International Tower Hill Mines Ltd
TO:ITH
|
0.010x |
|
New York Mortgage Trust, Inc.
NASDAQ:ADAM
|
-0.011x |
Annual Cash Flow Conversion Efficiency for Jiangsu Jibeier Pharmaceutical Co Ltd (2016–2025)
The table below shows the annual cash flow conversion efficiency of Jiangsu Jibeier Pharmaceutical Co Ltd from 2016 to 2025. View 688566 live share price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥2.45 Billion ≈ $358.46 Million |
CN¥248.30 Million ≈ $36.33 Million |
0.101x | +6.11% |
| 2024-12-31 | CN¥2.25 Billion ≈ $329.81 Million |
CN¥215.29 Million ≈ $31.50 Million |
0.096x | +14.41% |
| 2023-12-31 | CN¥1.91 Billion ≈ $279.55 Million |
CN¥159.50 Million ≈ $23.34 Million |
0.083x | -6.15% |
| 2022-12-31 | CN¥1.69 Billion ≈ $247.93 Million |
CN¥150.72 Million ≈ $22.06 Million |
0.089x | -4.97% |
| 2021-12-31 | CN¥1.61 Billion ≈ $235.34 Million |
CN¥150.56 Million ≈ $22.03 Million |
0.094x | +25.73% |
| 2020-12-31 | CN¥1.58 Billion ≈ $230.67 Million |
CN¥117.36 Million ≈ $17.17 Million |
0.074x | -69.66% |
| 2019-12-31 | CN¥470.46 Million ≈ $68.84 Million |
CN¥115.45 Million ≈ $16.89 Million |
0.245x | -10.41% |
| 2018-12-31 | CN¥357.68 Million ≈ $52.34 Million |
CN¥97.97 Million ≈ $14.34 Million |
0.274x | +8.12% |
| 2017-12-31 | CN¥440.76 Million ≈ $64.50 Million |
CN¥111.66 Million ≈ $16.34 Million |
0.253x | +134.16% |
| 2016-12-31 | CN¥363.15 Million ≈ $53.14 Million |
CN¥39.29 Million ≈ $5.75 Million |
0.108x | -- |
About Jiangsu Jibeier Pharmaceutical Co Ltd
Jiangsu Jibeier Pharmaceutical Co., Ltd., a pharmaceutical company, engages in the drug research and development and production in China. The company's products cover multiple therapeutic areas such as increasing white blood cells, fighting hypertension, enhancing immunity, treating joint diseases, fighting eye infections, treating bronchitis, protecting liver function, etc. It is also developing… Read more